We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.45%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$520M
AUM Growth
+$3.52M
(+0.68%)
Cap. Flow
+$20.7M
Cap. Flow
% of AUM
3.98%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mineralys Therapeutics
MLYS
|
+$10.3M |
| 2 |
TSVT
2seventy bio
TSVT
|
+$5.44M |
| 3 |
Vera Therapeutics
VERA
|
+$4.63M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$4.57M |
| 5 |
Treace Medical Concepts
TMCI
|
+$4.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$5.52M |
| 3 |
iRhythm Holdings
IRTC
|
+$4.01M |
| 4 |
Arrowhead Research
ARWR
|
+$3.87M |
| 5 |
HealthEquity
HQY
|
+$3.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$8.22B
| $6.51M | 1.25% |
231,100
-800
| -0.3% | -$21.8K |
|
27
Inspire Medical Systems
INSP
$1.45B
| $6.44M | 1.24% |
27,500
+9,300
| +51% | +$2.35M |
|
28
Pfizer
PFE
$143B
| $6.42M | 1.23% |
157,400
+28,000
| +22% | +$1.21M |
|
29
AbbVie
ABBV
$443B
| $6.26M | 1.2% |
39,300
+2,000
| +5% | +$306K |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.18M | 1.19% |
114,200
-8,250
| -7% | -$399K |
|
31
Tenet Healthcare
THC
$20.5B
| $6.03M | 1.16% |
101,500
| – | – |
|
|
AXNX
32
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6M | 1.15% |
109,950
+22,304
| +25% | +$1.3M |
|
33
Prothena Corp
PRTA
$425M
| $5.95M | 1.14% |
122,750
+7,550
| +7% | +$399K |
|
34
Merck
MRK
$322B
| $5.85M | 1.12% |
55,000
| – | – |
|
|
FOLD
35
DELISTED
Amicus Therapeutics
FOLD
| $5.77M | 1.11% |
519,982
+12,300
| +2% | +$152K |
|
36
Denali Therapeutics
DNLI
$3.65B
| $5.64M | 1.08% |
244,850
+1,000
| +0.4% | +$27.5K |
|
37
Arvinas
ARVN
$518M
| $5.6M | 1.08% |
205,114
-34,133
| -14% | -$1.08M |
|
|
BLU
38
DELISTED
BELLUS Health Inc.
BLU
| $5.53M | 1.06% |
767,829
+98,800
| +15% | +$766K |
|
|
BPMC
39
DELISTED
Blueprint Medicines
BPMC
| $5.48M | 1.05% |
121,900
+6,000
| +5% | +$270K |
|
|
GRTX
40
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $5.37M | 1.03% |
2,098,565
+431,899
| +26% | +$891K |
|
41
Arcus Biosciences
RCUS
$3.55B
| $5.36M | 1.03% |
293,646
+55,164
| +23% | +$1.05M |
|
42
Alnylam Pharmaceuticals
ALNY
$27.5B
| $5.32M | 1.02% |
26,570
+3,760
| +16% | +$790K |
|
43
Amgen
AMGN
$208B
| $5.3M | 1.02% |
21,920
+4,000
| +22% | +$982K |
|
|
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.26M | 1.01% |
1,253,300
+273,000
| +28% | +$1.42M |
|
45
ARS Pharmaceuticals
SPRY
$509M
| $5.17M | 0.99% |
793,587
+11,177
| +1% | +$85.9K |
|
46
Boston Scientific
BSX
$69.5B
| $5.1M | 0.98% |
101,976
-12,000
| -11% | -$566K |
|
|
KRTX
47
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.88M | 0.94% |
26,880
+5,070
| +23% | +$970K |
|
|
TSVT
48
DELISTED
2seventy bio
TSVT
| $4.86M | 0.93% |
+476,000
| New | +$5.44M |
|
|
MRTX
49
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.77M | 0.92% |
128,406
+61,560
| +92% | +$2.77M |
|
|
50
Vera Therapeutics
VERA
$2.3B
| $4.66M | 0.9% |
+600,300
| New | +$4.63M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Sectoral Asset Management held 129 positions worth $520M, up 0.68% from $517M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Sectoral Asset Management deployed $20.7M of net new capital in Q1 2023, opening 9 new positions and adding to 50 existing holdings. Its largest new stake was Mineralys Therapeutics: 613,233 shares worth $9.6M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 95% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was R1 RCM Inc. Common Stock, an estimated $5.52M trimmed.
- Sectoral Asset Management's largest Q1 2023 buy was Mineralys Therapeutics: 613,233 shares worth $9.6M.
- Sectoral Asset Management added most to Shockwave Medical, Inc. Common Stock in Q1 2023, an estimated $4.57M increase.
- Sectoral Asset Management's biggest Q1 2023 reduction was R1 RCM Inc. Common Stock, cutting an estimated $5.52M.
- Sectoral Asset Management fully exited Exelixis in Q1 2023, selling an estimated $8.88M.
- Sectoral Asset Management's ten largest holdings make up 24% of its $520M portfolio in Q1 2023.
- Sectoral Asset Management opened 9 new positions and closed 11 in Q1 2023.
- Sectoral Asset Management's portfolio value rose 0.68% quarter-over-quarter to $520M.
Based on Sectoral Asset Management's 13F filing for Q1 2023, filed 12 May 2023.